Log In
Print this Print this

Niox Mino

  Manage Alerts
Collapse Summary General Information
Company Circassia Pharmaceuticals plc
DescriptionHandheld point-of-care device to measure fractional exhaled nitric oxide (FeNO) as an assessment of airway inflammation
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInflammation, Diagnostic
Indication DetailsMeasure airway inflammation to diagnose asthma; Treat asthma
Regulatory Designation
PartnerShanghai Pharmaceuticals Holding Co. Ltd.;
Stallergenes Greer plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today